308361-47-9

Usage

Molecular structure

2-(2-butyl)-4-[4-(piperazin-1-yl)phenyl]-2H-1,2,4-triazol-3-one has a complex molecular structure that includes a 1,2,4-triazole ring, a piperazine ring, a butyl group, and a phenyl group.

Pharmaceutical potential

The compound may have pharmaceutical potential due to its structural features. Both triazole and piperazine derivatives are commonly found in various medicinal compounds.

Chemical properties

The butyl and phenyl groups in the compound may contribute to its chemical properties and potential applications. These groups can influence the compound's solubility, stability, and reactivity.

Further study and analysis

To determine the potential uses and effects of 2-(2-butyl)-4-[4-(piperazin-1-yl)phenyl]-2H-1,2,4-triazol-3-one, it may require additional research, experimentation, and analysis. This could involve testing the compound's bioavailability, toxicity, and efficacy in various biological systems.

Upstream product

• 155431-45-1 4-[4-(4-benzyl-1-piperazinyl)phenyl]-3(2H,4H)-1,2,4-triazolone 
• 864932-60-5 C₂₃H₂₉N₅O 

Relevant academic research and scientific papers

SMALL MOLECULE INHIBITORS OF FIBROSIS

Described herein are compounds and compositions for the treatment of a fibrotic disease.

SMALL MOLECULE INHIBITORS OF FIBROSIS

Described herein are compounds and compositions for the treatment of a fibrotic disease.

MTP INHIBITING ARYL PIPERIDINES OR PIPERAZINES SUBSTITUTED WITH 5-MEMBERED HETEROCYCLES

The present invention is concerned with novel aryl piperidine or piperazine compounds substituted with certain 5-membered heterocycles having apoB secretion/MTP inhibiting activity and concomitant lipid lowering activity. The invention further relates to methods for preparing such compounds, pharmaceutical compositions comprising said compounds as well as the use of said compounds as a medicine for the treatment of hyperlipidemia, obesity and type II diabetes (Formula (I)). The invention further relates to methods for preparing such compounds, pharmaceutical compositions comprising said compounds as well as the use of said compounds as a medicine for the treatment of atherosclerosis, pancreatitis, obesity, hyper-triglyceridemia, hypercholesterolemia, hyperlipidemia, diabetes and type II diabetes.

NEW TRIAZOLES AS THERAPEUTIC AGENTS FOR FUNGAL INFECTIONS

A compound of formula (I), or an optical isomer or pharmaceutically acceptable salt thereof, is disclosed as well as a pharmaceutical composition and a method of treating or preventing a fungal infection using the compound.